The history of rhesus prophylaxis with anti-D

Bowman JM (1977) Rh-isoimmunization 1977, Modern Medicine of Canada 32: 17–25

Clarke CA, Donohoe WTA, McConnell RB, Woodrow JC, Finn R, Krevans JR, Kulke W, Lehane D, Sheppard PM (1963) Further experimental studies on the prevention of Rh haemolytic disease. BMJ 11: 979–984

Clarke CA, Sheppard PM (1965) Prevention of rhesus haemolytic disease. Lancet 11: 343

Finn R (1960) Erythroblastosis. Lancet I: 526

Finn R, Clarke CA, Donohoe WTA, McConnel RB, Sheppard PM, Lehane D, Kulke W (1961) Experimental studies on the prevention of Rh haemolytic disease. BMJ 11: 1486–1490

Freda J, Gorman JG, Pollack W (1963) Successful prevention of sensitization to Rh with an experimental anti-Rh gamma2-globulin antibody preparation. Fed Proc 22:374

Freda J, Gorman JG, Pollack W (1965) Prevention of rhesus haemolytic disease. Lancet 11: 690

Freda VJ, Gorman JG, Pollack W, Robertson JG, Jennings ER, Sullivan JF (1967) Prevention of Rh isoimmunization. JAMA 199:390–394

Freda VJ, Gorman JG, Galen RS, Treacy N (1970) The threat of Rh immunisation from abortion. Lancet II: 147–148

Gorman JG (1971) Analysis of failures with Rh-immune globulin. Clin Obstet Gynecol 14:635–646

Gorman JG, Freda VJ, Pollack W (1964) Prevention of sensitization to Rh with anti-Rh gamma globulin. Fred Proc 23:238

Holburn AM, Frame M, Hughes-Jones NC, Mollison PL (1971) Some biological effects of IgM anti-Rh (D). Immunology 20:681–691

Hughes-Jones NC, Gardner B (1970) The equilibrium constants of anti-D immunoglobulin preparations made from pools of donor plasma. Immunology 18:347–351

Jandl JH, Jones AR, Castle WB (1957) The destruction of red cells by antibodies in man. Observations on the sequestration and lysis of red cells altered by immune mechanisms. J Clin Invest 36:1428–1459

Kleihauer E, Braun H, Betke K (1957) Demonstration von fetalem Hämoglobin in den Erythrocyten eines Blutausstrichs. Klin Wochenschr 35:637–638

Landsteiner K, Wiener AS (1940) An agglutinable factor in human blood recognized by immune sera for Rhesus blood. Proc Soc Biol Med 43:223

Levine P (1943) Serological factors as possible causes in spontaneous abortions. J Hered 34:71–80

Levine P, Katzim EM, Burnham L (1941) Isoimmunization in pregnancy: its possible bearing on the etiology of erythroblastosis foetalis. JAMA 116:825–827

Pollack W, Ascari WQ, Crispen JF, O'Connor RR, Ho TY (1971) Studies on Rh prophylaxis. II. Rh imune prophylaxis after transfusion with Rh-positive blood. Transfusion 11:340–344

Schneider J (1963) Die quantitative Bestimmung fetaler Erythrocyten im müt-terlichen Kreislauf und deren beschleunigter Abbau durch Antikörperseren. Geburtshilfe Frauenheilkd 23:562–568

Schneider J (1971) Tagungsberichte. IV. Arbeitstagung zur Prophylaxe der Rhesus-Sensibilisierung mit Immunglobulin-Anti-D. Geburtshilfe Frauenheilkd 31:493–522

Schneider J, Behrens O (1992) Rhesus-problem heute. Gynäkologe 25:36–40

Stern K, Davidson I, Masaitis L (1956) Experimental studies on Rh immunization. Am J Clin Pathol 26:833–843

Stern K, Goodman H, Berger M (1961) Experimental immunization to hemoantigens in man. J Immunol 87:189–198

Trolle B (1989) Prenatal Rh-immune prophylaxis with 300 μg immune globulin anti-D in the 28th week of pregnancy. Acta Obstet Gynecol Scand 68:45–47

Woodrow JC, Finn R (1966) Transplacental haemorrhage. Br J Haematol 12:297–309

Woodrow JC, Clarke CA, McConnell RB, Towers SH, Donohoe WTA (1971) Prevention of Rh-haemolytic disease: results of the liverpool “low risk” clinical trial. BMJ 11:610–612

Zipursky A, Pollock J, Neelands P, Chown B, Israels LG (1963) The transplacental passage of foetal red blood-cells and the pathogenesis of Rh immunization during pregnancy. Lancet II:489–493